Hypertension

Journal

Publication Venue For

  • Changes in the Prevalence of Chronic Hypertension in Pregnancy, United States, 1970 to 2010.  74:1089-1095. 2019
  • Sex Differences in Hypertension and Stroke Risk in the REGARDS Study: A Longitudinal Cohort Study.  74:749-755. 2019
  • Masked uncontrolled hypertension is not attributable to medication nonadherence.  74:652-659. 2019
  • Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEART.  74:276-284. 2019
  • Gut microbiota composition and blood pressure: The CARDIA study.  73:998-1006. 2019
  • Blood Pressure and Cognitive Decline over 8 Years in Middle-Aged and Older Black and White Americans.  73:310-318. 2019
  • Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.  73:327-334. 2019
  • Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.  73:132-141. 2019
  • Resistant hypertension: Detection, evaluation, and management a scientific statement from the American Heart Association.  72:E53-E90. 2018
  • Blood pressure patterns and subsequent coronary artery calcification in women who delivered preterm births.  72:159-166. 2018
  • Case of refractory hypertension controlled after aortic and mitral valve replacement and coronary artery bypass grafting.  72:3-9. 2018
  • FGF23 (fibroblast growth factor-23) and incident hypertension in young and middle-aged adults: The CARDIA study.  72:70-76. 2018
  • Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial).  71:848-857. 2018
  • Medical versus surgical treatment of primary aldosteronism.  71:566-568. 2018
  • Accuracy of blood pressure measurement devices in pregnancy: A systematic review of validation studies.  71:326-335. 2018
  • Impact of intensive versus standard blood pressure management by tertiles of blood pressure in SPRINT (Systolic Blood Pressure Intervention Trial).  71:1064-1074. 2018
  • Refractory hypertension is not attributable to intravascular fluid retention as determined by intracardiac volumes.  72:343-349. 2018
  • White-Coat Effect Is Uncommon in Patients with Refractory Hypertension.  70:645-651. 2017
  • Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries among Older Treated Adults with Hypertension.  70:259-266. 2017
  • Cardiovascular Health and Incident Hypertension in Blacks :JHS (The Jackson Heart Study).  70:285-292. 2017
  • Mechanisms and Treatment of Halogen Inhalation-Induced Pulmonary and Systemic Injuries in Pregnant Mice.  70:390-400. 2017
  • Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.  70:461-468. 2017
  • Trends in Prehypertension and Hypertension Risk Factors in US Adults 1999-2012.  70:275-284. 2017
  • Hypertension in Women: Recent Advances and Lingering Questions.  70:19-26. 2017
  • Resistant Hypertension: An Update of Experimental and Clinical Findings.  70:5-9. 2017
  • Distinctive Risk Factors and Phenotype of Younger Patients with Resistant Hypertension: Age is Relevant.  69:827-835. 2017
  • Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study).  69:761-769. 2017
  • Hypertension and Its Complications in a Young Man with Autoimmune Disease.  69:536-544. 2017
  • Physical activity and incident hypertension in African Americans.  69:421-427. 2017
  • On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults with Isolated Systolic Hypertension.  69:220-227. 2017
  • Cardiovascular Risk Factors and Masked Hypertension: The Jackson Heart Study.  68:1475-1482. 2016
  • Sympathetic Activity, Hypertension, and the Importance of a Good Night's Sleep.  68:1338-1339. 2016
  • Research Needs to Improve Hypertension Treatment and Control in African Americans.  68:1066-1072. 2016
  • Research needs to improve hypertension treatment and control in African Americans.  68:1066-1072. 2016
  • Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients with Resistant Hypertension.  68:995-1003. 2016
  • Trends in antihypertensive medication discontinuation and low adherence among medicare beneficiaries initiating treatment from 2007 to 2012.  68:565-575. 2016
  • Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.  68:501-510. 2016
  • Masked Hypertension and Incident Clinic Hypertension Among Blacks in the Jackson Heart Study.  68:220-226. 2016
  • The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.  68:39-45. 2016
  • Visit-to-Visit Variability in Blood Pressure Is Related to Late-Life Cognitive Decline.  68:106-113. 2016
  • Longitudinal patterns of change in systolic blood pressure and incidence of cardiovascular disease: The atherosclerosis risk in communities study.  67:1150-1156. 2016
  • Refractory hypertension: A novel phenotype of antihypertensive treatment failure.  67:1085-1092. 2016
  • Introduction to the American Heart Association's hypertension strategically focused research network.  67:674-680. 2016
  • Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial.  67:550-555. 2016
  • Obesity, African American Race, Chronic Kidney Disease, and Resistant Hypertension: The Step beyond Observed Risk.  67:275-277. 2016
  • SPRINT Trial Results: Latest News in Hypertension Management.  67:263-265. 2016
  • Treatment of Hypertension in Patients with Coronary Artery Disease: A Scientific Statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension.  65:1372-1407. 2015
  • Determinants of aortic root dilatation and reference values among young adults over a 20-year period: Coronary artery risk development in young adults study.  66:23-29. 2015
  • New Clues Towards Solving the Mystery of Endothelin and Blood Pressure Regulation.  66:275-277. 2015
  • Refractory hypertension: Evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure.  66:126-133. 2015
  • Should acetaminophen be added to the list of anti-inflammatory agents that are associated with cardiovascular events?.  65:991-992. 2015
  • Transcription factor avian erythroblastosis virus E26 oncogen homolog-1 is a novel mediator of renal injury in salt-sensitive hypertension.  65:813-820. 2015
  • Determination of prevalence, risk factors, and comorbidities in a large, population-based cohort.  63:451-458. 2014
  • Response to comment on optimal treatment for resistant hypertension: The missing data on pulse wave velocity.  63. 2014
  • 2013 Dahl Lecture American heart association council for high blood pressure research clarifying the physiology of endothelin.  63. 2014
  • Adverse childhood experiences are associated with detrimental hemodynamics and elevated circulating endothelin-1 in adolescents and young adults.  64:201-207. 2014
  • Effects of the once-weekly glucagon-like peptide-1 receptor agonist dulaglutide on ambulatory blood pressure and heart rate in patients with type 2 diabetes mellitus.  64:731-737. 2014
  • Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: The Reasons for Geographic and Racial Differences in Stroke study.  64:465-471. 2014
  • Response to should more significance be granted to medication response to antihypertensives in patients with resistant hypertension?.  63. 2014
  • Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).  64:1012-1021. 2014
  • Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality a systematic review and meta-analysis.  64:965-982. 2014
  • Transforming growth factor-β regulates endothelial function during high salt intake in rats.  62:951-956. 2013
  • Evaluating the Framingham hypertension risk prediction model in young adults: The Coronary Artery risk Development in Young Adults (CARDIA) study.  62:1015-1020. 2013
  • Increased circulating inflammatory endothelial cells in blacks with essential hypertension.  62:585-591. 2013
  • Renal collecting duct nos1 maintains fluid-electrolyte homeostasis and blood pressure.  62:91-98. 2013
  • Mortality and morbidity during and after antihypertensive and lipid-lowering treatment to prevent heart attack trial: Results by sex.  61:977-986. 2013
  • The amiloride-sensitive endothelial sodium channel and vascular tone.  61:952-954. 2013
  • What are the key arguments against uric acid as a true risk factor for hypertension?.  61:948-951. 2013
  • Endothelin, kidney disease, and hypertension.  61:1142-1145. 2013
  • Preterm birth and future maternal blood pressure, inflammation, and intimal-medial thickness: The CARDIA study.  61:641-646. 2013
  • Role of the transcription factor erythroblastosis virus E26 oncogen homolog-1 (ETS-1) as mediator of the renal proinflammatory and profibrotic effects of angiotensin II.  60:1226-1233. 2012
  • Uric acid reduction rectifies prehypertension in obese adolescents.  60:1148-1156. 2012
  • Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.  59:926-933. 2012
  • Midgestation maternal serum 25-hydroxyvitamin D level and soluble fms-like tyrosine kinase 1/placental growth factor ratio as predictors of severe preeclampsia.  58:1120-1125. 2011
  • Isolated diastolic hypotension and incident heart failure in older adults.  58:895-901. 2011
  • Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacity.  58:619-626. 2011
  • Erratum: Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat (Hypertension (2010) 56 (942-949)).  58. 2011
  • Uric acid: A clinically useful marker to distinguish preeclampsia from gestational hypertension.  58:548-549. 2011
  • Role of adenosine 5′-triphosphate in regulating renal microvascular function and in hypertension.  58:333-340. 2011
  • Sex differences in renal medullary endothelin receptor function in angiotensin ii hypertensive rats.  58:212-218. 2011
  • Response to intervisit blood pressure variability and outcome: Is heart rate a missing confounder?.  58. 2011
  • Ethnic differences in hypertension incidence among middle-aged and older adults: The multi-ethnic study of atherosclerosis.  57:1101-1107. 2011
  • P2X1 receptor-mediated vasoconstriction of afferent arterioles in angiotensin II-infused hypertensive rats fed a high-salt diet.  57:780-787. 2011
  • Mechanisms underlying hypertension and obesity: A melanocortin linkage in the brain.  57:375-376. 2011
  • High dietary protein exacerbates hypertension and renal damage in dahl SS rats by increasing infiltrating immune cells in the kidney.  57:269-274. 2011
  • The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: Findings from NHANES III, 1988 to 1994.  57:160-166. 2011
  • Ethnic differences in hypertension incidence among middle-aged and older adults: The multi-ethnic study of atherosclerosis.  57:1101-1107. 2011
  • Geographic and demographic variability in 20-year hypertension incidence: The CARDIA study.  57:39-47. 2011
  • Resistant hypertension: Bad and getting worse.  57:1045-1046. 2011
  • Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat.  56:942-949. 2010
  • Ethnic Differences in Incident Hypertension among Middle Age and Older Adults: The Multi-Ethnic Study of Atherosclerosis.  56:E88-E88. 2010
  • Interleukin 6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation.  56:879-884. 2010
  • Salt and aldosterone: A concert of bad effects.  56:804-805. 2010
  • Response to hyperaldosteronism and left ventricular hypertrophy.  56. 2010
  • Endothelin activation of reactive oxygen species mediates stress-induced pressor response in dahl salt-sensitive prehypertensive rats.  56:282-289. 2010
  • Dissecting the complex physiology of endothelin: New lessons from genetic models.  56:31-33. 2010
  • Joint associations of physical activity and aerobic fitness on the development of incident hypertension: Coronary artery risk development in young adults.  56:49-55. 2010
  • Response to c-reactive protein and cardiovascular disease: Differences between humans and mice.  56. 2010
  • Comparison of the framingham heart study hypertension model with blood pressure alone in the prediction of risk of hypertension: The multi-ethnic study of atherosclerosis.  55:1339-1345. 2010
  • The transcription factor ETS-1 mediates proinflammatory responses and neointima formation in carotid artery endoluminal vascular injury.  55:1381-1388. 2010
  • Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: A prospective clinical study.  55:1137-1142. 2010
  • C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.  55:953-960. 2010
  • Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the zucker obese rat.  55:880-888. 2010
  • Response to "effective" plasma renin activity: A derived measure for assessing residual plasma renin activity in patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.  55. 2010
  • Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction.  55:241-248. 2010
  • Response to role of epithelial sodium channels in the renal myogenic response?.  55. 2010
  • Mammalian target of rapamycin: Mastor mediator of cellular changes in pathological states?.  54:1221-1222. 2009
  • Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome?.  54:954-955. 2009
  • Effect of epithelial sodium channel blockade on the myogenic response of rat juxtamedullary afferent arterioles.  54:1062-1069. 2009
  • Potassium inhibits dietary salt-induced transforming growth factor-β production.  54:1159-1163. 2009
  • Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: Results from a randomized trial.  54:475-481. 2009
  • Novel role of fumarate metabolism in dahl-salt sensitive hypertension.  54:255-260. 2009
  • Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: A randomized clinical trial.  54:32-39. 2009
  • Hormone therapy of premature ovarian failure the case for "natural" estrogen.  53:745-746. 2009
  • Aldosterone and metabolic dysfunction an unresolved issue.  53:585-586. 2009
  • Dietary salt intake, salt sensitivity, and cardiovascular health.  53:442-445. 2009
  • Isolated systolic hypertension and incident heart failure in older adults: A propensity-matched study.  53:458-465. 2009
  • Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute family heart study.  53:473-479. 2009
  • Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats..  53:324-330. 2009
  • Genetic effect on blood pressure is modulated by age the hypertension genetic epidemiology network study.  53:35-41. 2009
  • Mysteries of renal autoregulation.  53:299-306. 2009
  • Dietary salt activates an endothelial proline-rich tyrosine kinase 2/c-Src/phosphatidylinositol 3-kinase complex to promote endothelial nitric oxide synthase phosphorylation.  52:1134-1141. 2008
  • Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.  52:1084-1090. 2008
  • Association between different measures of blood pressure and coronary artery calcium in postmenopausal women.  52:833-840. 2008
  • Role of endothelin-1 in clinical hypertension: 20 years on.  52:452-459. 2008
  • Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: A losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.  52:279-286. 2008
  • Postnatal intermittent hypoxia and developmental programming of hypertension in spontaneously hypertensive Rats: The role of reactive oxygen species and L-Ca 2+ channels.  52:156-162. 2008
  • Thiazide-induced dysglycemia: Call for research from a working group from the national heart, lung, and blood institute.  52:30-36. 2008
  • Collecting duct-derived endothelin regulates arterial pressure and Na excretion via nitric oxide.  51:1605-1610. 2008
  • Effects of losartan in women with hypertension and left ventricular hypertrophy: Results from the Losartan Intervention For Endpoint reduction in hypertension study.  51:1103-1108. 2008
  • Salt sensitivity: It is not always in the genes.  51:823-824. 2008
  • Racial differences in microalbumin excretion in healthy adolescents.  51:334-338. 2008
  • Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.  51:339-344. 2008
  • Response to about an epidemic of primary aldosteronism [2].  51. 2008
  • Vascular stiffness and the "chicken-or-the-egg" question.  51:177-178. 2008
  • Chemokine receptor 2b inhibition provides renal protection in angiotensin II-salt hypertension.  50:1069-1076. 2007
  • Is there an unrecognized epidemic of primary aldosteronism? (Pro).  50:447-458. 2007
  • Novel nitric oxide synthase-dependent mechanism of vasorelaxation in small arteries from hypertensive rats.  49:893-901. 2007
  • β1 integrins modulate β-adrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling.  49:865-872. 2007
  • Exaggerated cardiovascular stress responses and impaired β-adrenergic-mediated pressor recovery in obese Zucker rats.  48:1109-1115. 2006
  • Is there a new treatment for hypertensive disease in the horizon? Role of soluble guanylate cyclase.  48:822-823. 2006
  • Aldosterone, dietary salt, and renal disease.  48:209-210. 2006
  • Clarifying endothelin type B receptor function.  48:211-212. 2006
  • Nephron number, uric acid, and renal microvascular disease in the pathogenesis of essential hypertension.  48:25-26. 2006
  • Pathways by which dietary salt affects blood pressure and the nervous system.  47:638-639. 2006
  • Blood pressure reactivity to psychological stress and coronary calcification in the coronary artery risk development in young adults study.  47:391-395. 2006
  • NOS3 regulation: Renal tubular epithelial cells are not simply large endothelial cells.  47:19-21. 2006
  • A population association study of angiotensinogen polymorphisms and haplotypes with left ventricular phenotypes.  46:1294-1299. 2005
  • Hypertension 2005
  • Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats.  46:806-811. 2005
  • Impaired Ca2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension.  46:562-568. 2005
  • Improvement of blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension.  46:469-470. 2005
  • Peroxisome proliferator-activated receptor-α activation reduces salt-dependent hypertension during chronic endothelin B receptor blockade.  46:366-371. 2005
  • Endothelin, angiotensin, and oxidative stress in hypertension.  45:477-480. 2005
  • Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.  45:580-585. 2005
  • Sexual dimorphism in renal production of prostanoids in spontaneously hypertensive rats.  45:406-411. 2005
  • Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.  45:326-330. 2005
  • NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.  45:283-287. 2005
  • An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension..  46:975-981. 2005
  • Pulse pressure and coronary atherosclerosis progression in postmenopausal women.  45:53-57. 2005
  • Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study.  45:198-202. 2005
  • Resurrection of uric acid as a causal risk factor in essential hypertension.  45:18-20. 2005
  • Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: The Losartan Intervention for Endpoint reduction in hypertension study.  45:46-52. 2005
  • Effects of NOS3 Glu298Asp polymorphism on hemodynamic reactivity to stress: Influences of ethnicity and obesity.  44:866-871. 2004
  • Arterial pressure response to the antioxidant tempol and ETB receptor blockade in rats on a high-salt diet.  44:770-775. 2004
  • Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling.  44:746-750. 2004
  • Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice.  44:259-263. 2004
  • Insulin resistance and hypertension: The insulin resistance atherosclerosis study.  43:1324-1331. 2004
  • Reduced NOS3 Phosphorylation Mediates Reduced NO/cGMP Signaling in Mesenteric Arteries of Deoxycorticosterone Acetate-Salt Hypertensive Rats.  43:1080-1085. 2004
  • Salt Intake, Endothelial Cell Signaling, and Progression of Kidney Disease.  43:142-146. 2004
  • Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.  42:1206-1252. 2003
  • Endothelin-1 gene LYS198ASN polymorphism and blood pressure reactivity.  42:494-499. 2003
  • Hormone replacement therapy and inflammation: Interactions in cardiovascular disease.  42:657-663. 2003
  • A genome-wide scan for urinary albumin excretion in hypertensive families.  42:291-296. 2003
  • Hyperuricemia in childhood primary hypertension.  42:247-252. 2003
  • Na+/Ca2+ exchanger: Target for oxidative stress in salt-sensitive hypertension.  42:363-368. 2003
  • Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport.  42:195-199. 2003
  • Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse.  42:88-95. 2003
  • Functional role of ETB receptors in the renal medulla.  41:1359-1363. 2003
  • Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.  41:1183-1190. 2003
  • Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Practical implications.  41:1006-1009. 2003
  • Estrogen depletion increases blood pressure and hypothalamic norepinephrine in middle-aged spontaneously hypertensive rats.  41:1164-1167. 2003
  • α2A-adrenergic receptors mediate sympathoinhibitory responses to atrial natriuretic peptide in the mouse anterior hypothalamic nucleus.  41:571-575. 2003
  • Salt-Sensitive Hypertension After Exposure to Angiotensin Is Associated With Inability to Upregulate Renal Epoxygenases.  42:775-780. 2003
  • Hyperaldosteronism among black and white subjects with resistant hypertension.  40:892-896. 2002
  • The Na+/Ca2+ exchanger in salt sensitive hypertension.  40:416-416. 2002
  • Insulin sensitivity and blood pressure in black and white children.  40:18-22. 2002
  • Socioeconomic trajectories and incident hypertension in a biracial cohort of young adults.  39:772-776. 2002
  • Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice.  39:214-218. 2002
  • Increased dietary salt activates rat aortic endothelium.  39:239-244. 2002
  • Blood pressure and NaCl-sensitive hypertension are influenced by angiotensin-converting enzyme gene expression in transgenic mice..  39:214-218. 2002
  • Increased dietary salt activates rat aortic endothelium..  39:239-244. 2002
  • Interaction of α1-Na,K-ATPase and Na,K,2Cl-cotransporter genes in human essential hypertension.  38:204-209. 2001
  • Regeneration of the myocardium: A new role in the treatment of ischemic heart disease?.  38:1413-1415. 2001
  • Agmatine is an autocrine/paracrine inhibitor of pre-synaptic Ca plus plus channels and vasopressin release in vasopressinergic neurons of the hypothalamo-hypophyseal tract.  36:681-681. 2000
  • E-hypertension: Opening new vistas.  35:538. 2000
  • Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats..  35:403-408. 2000
  • Evidence for a gene influencing blood pressure on chromosome 17: Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study.  36:477-483. 2000
  • Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high nacl diets.  35:R500-R504. 2000
  • Racial differences in endothelin-1 at rest and in response to acute stress in adolescent males.  35:722-725. 2000
  • Afferent arteriolar vasodilation to the sulfonimide analog of 11,12- epoxyeicosatrienoic acid involves protein kinase A.  33:408-413. 1999
  • Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance.  33:1392-1398. 1999
  • Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection..  33:170-176. 1999
  • Low-renin and nonmodulating essential hypertension.  34:395-397. 1999
  • Purinoceptor-mediated calcium signaling in preglomerular smooth muscle cells.  33:195-200. 1999
  • Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension..  32:989-997. 1998
  • Calcium Mobilization Contributes to Pressure-Mediated Afferent Arteriolar Vasoconstriction.  31:421-428. 1998
  • Calcium mobilization contributes to pressure-mediated afferent arteriolar vasoconstriction..  31:421-428. 1998
  • Characteristics of 9194 patients with left ventricular hypertrophy: The LIFE study.  32:989-997. 1998
  • Concordant genetic and physiological data are required for candidate genes (multiple letters).  32:1104-1105. 1998
  • Hepatic denervation chronically elevates arterial pressure in Wistar- Kyoto rats.  32:46-51. 1998
  • Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.  31:1255-1260. 1998
  • Vascular smooth muscle nitric oxide synthase anomalies in Dahl/Rapp salt-sensitive rats.  31:918-924. 1998
  • Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function..  30:128-133. 1997
  • Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+from intracellular stores.  29:222-227. 1997
  • Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function.  30:128-133. 1997
  • Heritability of left ventricular mass: The Framingham Heart Study.  30:1025-1028. 1997
  • Long-term Effects on Sexual Function of Five Antihypertensive Drugs and Nutritional Hygienic Treatment in Hypertensive Men and Women: Treatment of Mild Hypertension Study (TOMHS).  29:8-14. 1997
  • Role of renal nerves in afferent arteriolar reactivity in angiotensin- induced hypertension.  29:442-449. 1997
  • Acute saline infusion decreases norepinephrine release in the anterior hypothalamic area..  27:578-583. 1996
  • Atrial natriuretic peptide blunts arterial baroreflex in spontaneously hypertensive rats.  27:297-302. 1996
  • Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks.  28:478-482. 1996
  • Salt intake and plasma atrial natriuretic peptide and nitric oxide in hypertension.  28:335-340. 1996
  • Acute hypertension increases norepinephrine release in the anterior hypothalamic area..  25:828-833. 1995
  • Gender and dietary NaCl in spontaneously hypertensive and Wistar-Kyoto rats.  26:285-289. 1995
  • Salt-induced hypertension in normotensive spontaneously hypertensive rats.  23:791-796. 1994
  • Salt-induced hypertension in normotensive spontaneously hypertensive rats..  23:791-796. 1994
  • Analysis of the genetic contamination of salt-sensitive Dahl/Rapp rats.  24:255-259. 1994
  • Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats.  24:1-7. 1994
  • Nitric oxide synthase isozymes characterization, purification, molecular cloning, and functions.  23:1121-1131. 1994
  • Renal apical membrane sodium-hydrogen exchange in genetic salt-sensitive hypertension.  24:491-498. 1994
  • Renal arteriolar angiotensin responses during varied adenosine receptor activation.  23:I-114-I-119. 1994
  • Angiotensin blockade reverses hypertension during long-term nitric oxide synthase inhibition.  21:660-666. 1993
  • Autonomic modulation of contractions to endothelin-1 in canine coronary arteries.  21:680-686. 1993
  • Coarctation induces alterations in basement membranes in the cardiovascular system.  22:743-753. 1993
  • Developmental sensitivity to high dietary sodium chloride in borderline hypertensive rats.  22:542-550. 1993
  • Effects of long-term air jet noise and dietary sodium chloride in borderline hypertensive rats.  22:527-534. 1993
  • Excitatory sympathetic reflex in NaCl-sensitive spontaneously hypertensive rats.  22:285-291. 1993
  • Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase.  21:934-938. 1993
  • Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat.  21:185-194. 1993
  • Normotensive blacks have heightened sympathetic response to cold pressor test.  22:801-805. 1993
  • Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.  22:812-818. 1993
  • Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats.  19:456-463. 1992
  • Atrial natriuretic peptide modulates baroreceptor reflex in spontaneously hypertensive rat.  20:374-379. 1992
  • Attenuated afferent arteriolar response to acetylcholine in goldblatt hypertension.  19:785-789. 1992
  • Blocking hypothalamic AT1 receptors lowers blood pressure in salt- sensitive rats.  20:755-762. 1992
  • Depressor effect of blocking angiotensin subtype 1 receptors in anterior hypothalamus.  19:475-481. 1992
  • Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.  19:198-205. 1992
  • Quantitation of hypothalamic atrial natriuretic peptide messenger RNA in hypertensive rats.  19:296-300. 1992
  • Salt supplementation does not alter the pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii.  20:242-246. 1992
  • High NaCl diet enhances arterial baroreceptor reflex in NaCl-sensitive spontaneously hypertensive rats.  17:363-368. 1991
  • Intrahypothalamic clonidine infusion prevents NaCl-sensitive hypertension.  18:224-229. 1991
  • Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation.  17:1033-1037. 1991
  • Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension.  15:748-752. 1990
  • Atrial natriuretic factor prevents NaCl-sensitive hypertension in spontaneously hypertensive rats.  15:170-176. 1990
  • Exaggerated natriuretic response to atrial natriuretic factor in rats developing spontaneous hypertension.  16:72-79. 1990
  • Genetic, neurohumoral, and hemodynamic influences on spontaneously hypertensive rat heart development in oculo.  15:247-256. 1990
  • Interleukin-2 does not attenuate hypertension in spontaneously hypertensive rats.  16:468-471. 1990
  • Atrial natriuretic factor in NaCl-sensitive and NaCl-resistant spontaneously hypertensive rats.  14:404-412. 1989
  • Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study.  14:218-226. 1989
  • Impaired reflex response to volume expansion in NaCl-sensitive spontaneously hypertensive rats.  14:518-524. 1989
  • Renal nerve contribution to NaCl-exacerbated hypertension in spontaneously hypertensive rats.  14:184-190. 1989
  • Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats..  11:739-744. 1988
  • Captopril and the response to stress in the spontaneously hypertensive rat..  11:I144-I147. 1988
  • Captopril and the response to stress in the spontaneously hypertensive rat.  11:I-144-I-147. 1988
  • High NaCl diet reduces hypothalamic norepinephrine turnover in hypertensive rats.  11:55-62. 1988
  • Impaired release of atrial natriuretic factor in NaCl-loaded spontaneously hypertensive rats.  11:739-744. 1988
  • Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat..  9:III171-III175. 1987
  • Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat.  9:III-171-III-175. 1987
  • Spontaneously hypertensive rats exhibit reduced hypothalamic noradrenergic input after NaCl loading.  10:313-320. 1987
  • Ventricular atriopeptin: Unmasking of messenger RNA and peptide synthesis by hypertrophy or dexamethasone.  9:485-491. 1987
  • Hypertension in a 74-year-old man with hydronephrosis and coronary disease..  7:824-833. 1985
  • Atriopeptins as cardiac hormones.  7:469-482. 1985
  • Hypertension in a 74-year-old man with hydronephrosis and coronary disease principal discussant.  7:824-833. 1985
  • Molecular studies of the atrial natriuretic factor gene.  7:31-34. 1985
  • Myocardial cell hypertrophy or hyperplasia.  6. 1984
  • Myocardial cell hypertrophy or hyperplasia..  6:III38-III43. 1984
  • Myocardial cell hypertrophy or hyperplasia.  6:38-43. 1984
  • Baseline physical examination characteristics of the hypertensive participants.  5. 1983
  • Hypertension detection and follow-up program. Baseline medical history characteristics of the hypertensive participants..  5. 1983
  • Altered vascular reactivity and baroreflex sensitivity induced by chronic central administration of captopril in the spontaneously hypertensive rat.  5:689-700. 1983
  • Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril.  5:653-662. 1983
  • Baseline medical history characteristics of the hypertensive participants.  5:51-91. 1983
  • Baseline physical examination characteristics of the hypertensive participants.  5:92-132. 1983
  • Kidney function and sodium handling in the pregnant spontaneously hypertensive rat.  5:498-506. 1983
  • Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.  5:427-435. 1983
  • Training and certification of blood pressure observers.  5:610-614. 1983
  • Importance of the renal nerves in the pathogenesis of experimental hypertension..  4:III108-III114. 1982
  • Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension..  4:166-174. 1982
  • 1982: A critical year for hypertension.  4:1-2. 1982
  • Central effects of prostaglandin E2 on blood pressure and plasma renin activity in rats role of the sympathoadrenal system and vasopressin.  4:809-816. 1982
  • Decrease in hypothalamic norepinephrine content following renal denervation in the one-kidney, one clip goldblatt hypertensive rat.  4:369-373. 1982
  • Importance of the renal Nerves in the Pathogenesis of Experimental Hypertension.  4:108-115. 1982
  • Importance of the renal nerves in established Two-Kidney, one clip goldblatt hypertension.  4:166-174. 1982
  • Influence of converting enzyme inhibition on renal hemodynamics and glomerular dynamics in sodium-restricted dogs.  4:58-68. 1982
  • The role of calcium in the control of renin release.  4:670-675. 1982
  • A progress report on hypertension.  3:1-3. 1981
  • Bilateral renal function responses to converting enzyme inhibitor (SQ 20,881) in two-kidney, one clip goldblatt hypertensive rats.  3:285-293. 1981
  • Role of the Renal Nerves in the Pathogenesis of One-Kidney Renal Hypertension in the Rat.  3:404-409. 1981
  • Hemodynamic Response to Vascular Expansion Following Immunosympathectomy in Spontaneously Hypertensive Rats.  2:304-310. 1980
  • Impact of hypertension information on high blood pressure control between 1973 and 1978.  2:708-713. 1980
  • Importance of Renal Sympathetic Tone in the Development of DOCA-Salt Hypertension in the Rat.  2:266-273. 1980
  • The first year of hypertension.  2:1-2. 1980
  • Glomerular and renal hemodynamics during converting enzyme inhibition (SQ20,881) in the dog.  1:371-377. 1979
  • Hypertension: A new journal.  1:1-2. 1979
  • Mechanism of angiotensin i converting enzyme inhibition by SQ20,881 (<Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo: Further evidence for extrapulmonary conversion.  1:13-22. 1979
  • Nomenclature for experimental renovascular hypertension. Report of the Nomenclature Committee of the Council for High Blood Pressure Research of the American Heart Association..  1:61. 1979
  • Regional myocyte size in normotensive and spontaneously hypertensive rats.  1:378-383. 1979
  • International Standard Serial Number (issn)

  • 0194-911X
  • Electronic International Standard Serial Number (eissn)

  • 1524-4563